Bin Lian, Yu Chen, Hui Wang, Weizhen Zhang, Xiaoshi Zhang, Meiyu Fang, Yuping Sun, Di Wu, Jiuwei Cui, Xinjun Liang, Ke Li, Huijing Feng, Qian Chu, Xingxiang Pu, Yueyin Pan, Meixing Sun, Maggie Zhou, Yuling Chen, Hongli Wang, Jun Guo. "Efficacy and safety results of a first-in-class PD-1/IL-2
            <sup>α-bias</sup>
            bispecific antibody fusion protein IBI363 in patients (pts) with immunotherapy-treated, advanced acral and mucosal melanoma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.2502